Fresenius Medical Care : Factsheet 2023

				40
				Around
4,000	Around
		Around
				production sites in around 20 countries
		More than	120,000
dialysis centers in around 50 countries

332,000 employees

patients worldwide 52M Around

dialysis treatments in 2023

The Company at a Glance

Financial Figures (in BN €)

19.45

Revenue

0.76 1.74

Net income1 exclu-	Operating income
ding special items	excluding special
and PRF2	items and PRF2

Who We Are

Fresenius Medical Care is the world's leading provider of products and services for people with renal disease. We serve more than 332,000 dialysis patients worldwide and provide products in around

150 countries. Our goal is not only to treat, but also to innovate, to improve the lives of those impacted by kidney disease.

Vision - Mission - Strategy	Chief Executive Officer and
Creating a future worth living. For	Chair of the Management Board
patients. Worldwide. Every day.	Helen Giza
This vision guides our company
to provide people across the renal
care continuum with outstanding
healthcare and high-quality
products. We aim to use our
innovative products and services
to offer sustainable solutions at a
reliable cost around the world. Our
commitment to sustainability is an
integral part of our strategy.

1. Net income attributable to shareholders of Fresenius Medical Care AG.
2. For FY 2023, special items include the costs related to the FME25 program, the Humacyte investment remeasurement, the costs associated with the legal form conversion and the effects from legacy portfolio optimization. For FY 2022,
   special items include the costs related­ to the FME25 program, the impact of the war in Ukraine, the impact of hyperinflation in Turkiye, the Humacyte investment ­remeasurement and the net gain related to InterWell Health. Additionally,
   FY 2022 was adjusted­ for the U.S. Provider Relief Funding (PRF). For further details please see the reconciliation attached to the press release for the 4th quarter 2023.